Meanwhile, miR-22 transferred from TAMs to glioma stem cells was able to promote mesenchymal phenotypes and induce radiotherapy resistance by targeting the chromodomain helicase DNA-binding protein 7 (CHD7), a chromodomain enzyme that maintains the proneural phenotype in glioblastoma [26]. This evidence concerns the gene CHD7 and glioma.